Form 8-K - Current report:
SEC Accession No. 0001437749-25-016877
Filing Date
2025-05-14
Accepted
2025-05-14 16:44:23
Documents
16
Period of Report
2025-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cont20250321_8k.htm   iXBRL 8-K 31652
2 EXHIBIT 99.1 ex_793225.htm EX-99.1 72753
7 logo.jpg GRAPHIC 8156
  Complete submission text file 0001437749-25-016877.txt   269107

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA noticker-20250514.xsd EX-101.SCH 3611
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE noticker-20250514_def.xml EX-101.DEF 11816
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE noticker-20250514_lab.xml EX-101.LAB 15848
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE noticker-20250514_pre.xml EX-101.PRE 12031
18 EXTRACTED XBRL INSTANCE DOCUMENT cont20250321_8k_htm.xml XML 2969
Mailing Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121 (858) 333-5280
Contineum Therapeutics, Inc. (Filer) CIK: 0001855175 (see all company filings)

EIN.: 271467257 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42001 | Film No.: 25946591
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)